ACADIA PHARMACEUTICALS INC Quarterly Depreciation in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from Q1 2011 to Q1 2024.
  • Acadia Pharmaceuticals Inc Depreciation for the quarter ending March 31, 2024 was $242K, a 43.2% decline year-over-year.
  • Acadia Pharmaceuticals Inc annual Depreciation for 2023 was $1.46M, a 28% decline from 2022.
  • Acadia Pharmaceuticals Inc annual Depreciation for 2022 was $2.03M, a 9.39% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Depreciation for 2021 was $2.24M, a 53.7% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $242K -$184K -43.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $426K -$90K -17.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $516K -$9K -1.71% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $525K +$231K +78.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $294K -$121K -29.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $415K +$23K +5.87% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $392K +$122K +45.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $270K +$132K +95.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2016 $138K +$16K +13.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $122K +$79K +184% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q1 2014 $43K +$31K +258% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $12K -$18K -60% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q1 2012 $30K -$159K -84.1% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-08
Q1 2011 $189K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.